Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-04

Clinical Trial Update: The Role of OXytocin in Acute Ischemic Stroke reconvAlesceNcE: The ROXANE Study

View source ↗

Summary

A clinical trial update for the ROXANE study assessing oxytocin in acute ischemic stroke. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxytocin (Oxytocin)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Acute Ischemic Stroke | Status: COMPLETED